Australian
-
Australian pharmaceuticals market: Top growth opportunities
Despite Australia being a mature market for pharmaceuticals, there will be steady growth in coming years due to easy public access to its well-managed healthcare system.
Australian | 01 May 2011
-
Constant innovation in Australian biotech
Dr Bornadata (Bonnie) Bain, global director of healthcare research and analysis, Datamonitor comments: “Pharma’s continued need to restock pipelines in order to secure future growth—in the face of ongoing patent expiries—maintains ongoi…
Australian | 09 November 2010
-
Overview of the Australian opioid market
There is an increase in prescription opioid use in recent years for both chronic and acute pain.
Australian | 01 September 2010
-
CBio Secures Clinical Trial Milestone
Australian drug development company CBio has announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk. The agreement relates to the development of XToll, a potential drug therap…
Australian | 01 April 2010
-
CBio Receives Approvals for Rheumatoid Arthritis Trials
Australian-based drug development company CBio has announced a milestone achievement in its research in the treatment of rheumatoid arthritis. Jason Yeates, MD, said that human research ethics committee approvals have been received for all Centra…
Australian | 18 March 2010
-
Biotron Progresses HIV Clinical Trial in Australia
An international AIDS conference has been told that an Australian anti-viral drug in development is able to stop the virus spreading. The drug, developed by Sydney based company Biotron and known as BIT225 was tested in a study involving 18 HIV p…
Australian | 24 December 2009
-
Australian Government Stockpiles 1.6 million Courses of Relenza
Biota Holdings has announced that the Australian government has purchased an additional 1.6 million courses of Relenza for the National Medical Stockpile to bolster supplies of antiviral drugs to treat pandemic influenza. The purchase cost is A$43 mi…
Australian | 08 June 2009
-
ClinPhone Opens New Australian Office to Service Asia-Pacific Region
Clinical technology solutions provider ClinPhone is opening new offices in Melbourne, Australia, following the company’s growing success in the Asia-Pacific region. The new facility, which is due to open on 31 October 2006, will provide ClinPhoneâ…
Australian | 01 September 2007
-
Investment Strengthens Australian’s HMR Sector
The Federal Government has pumped $500 million in supporting Australian health and medical research (HMR) by further boosting investment in the nation’s Budget. “New spending of over $500 million in HMR is a strategic investment and will a…
Australian | 22 May 2007
-
Bio3 Research Granted By The Australian PO A Patent In The Field Of HMGB1
Bio3 Research S.r.l. said the Australian Patent Office has granted the company the patent in the HMGB1 (High Mobility Group Box 1 protein) field which entitles the use of antagonist molecules (Mabs and their fragments, Small Molecules inhibitors and …
Australian | 17 March 2007
